Skip to main content

Free patient guide · 19 pages · PDF

Stem Cell Therapy for Liver Disease: A Patient's Guide

Regenerating Liver Tissue and Restoring Hepatic Function

· Medically reviewed by SCL Medical Team

What is inside this guide

  1. Understanding Liver Disease
  2. How Stem Cell Therapy Helps
  3. Treatment at StemCell Longevita
  4. Results & Recovery
  5. Getting Started

Chapter 1

Understanding Liver Disease

Chronic Liver Disease Overview

Chronic liver disease encompasses conditions that progressively damage the liver over months to years. Common causes include alcohol-related liver disease, non-alcoholic fatty liver disease (NAFLD/NASH), viral hepatitis, autoimmune hepatitis, and metabolic liver diseases. Progressive liver damage leads to fibrosis, cirrhosis, and potentially liver failure or liver cancer.

Stages of Liver Disease

The liver is one of the most regenerative organs in the body, but chronic disease can overwhelm its repair capacity. Stem cell therapy amplifies the liver's natural regenerative mechanisms.

  • Inflammation — Initial liver damage causes inflammation (hepatitis) that may be asymptomatic.
  • Fibrosis — Chronic inflammation leads to scar tissue formation, graded F1 to F3.
  • Cirrhosis (F4) — Extensive scarring replaces functional liver tissue, causing significant liver dysfunction.
  • Decompensated cirrhosis — Advanced stage with complications including jaundice, ascites, and hepatic encephalopathy.

Chapter 2

How Stem Cell Therapy Helps

Hepatic Repair Mechanisms

MSCs promote liver repair by secreting hepatocyte growth factor and other liver-protective cytokines, reducing hepatic stellate cell activation (the primary driver of fibrosis), stimulating hepatocyte proliferation to replace damaged cells, modulating the hepatic immune environment, and improving liver blood flow and microcirculation. Clinical trials have demonstrated that MSC therapy can reduce liver fibrosis scores by 1 to 2 stages on the METAVIR scale, improve Child-Pugh scores, and reduce MELD scores in cirrhosis patients.

Clinical Results

68%
Improved Liver Function
52%
Fibrosis Score Reduction
74%
Improved Quality of Life

Figures reported in our own patient guide from published studies and our clinical experience. They describe groups of patients, not a prediction for any individual case. See the evidence we rely on.

Chapter 3

Treatment at StemCell Longevita

Our Liver Protocol

We use high-dose IV infusion of umbilical cord-derived MSCs, leveraging the liver's first-pass effect to maximize hepatic cell delivery. Treatment is administered over 3 to 4 sessions during a 5-day stay. For patients with advanced cirrhosis, hepatic artery delivery may be considered.

Treatment at Liv Hospital Ulus

  • Day 1 — Comprehensive liver evaluation including liver function tests, fibrosis assessment (FibroScan), and imaging.
  • Day 2-4 — Sequential stem cell IV infusions with liver function monitoring.
  • Day 5 — Post-treatment assessment, lifestyle guidance, and discharge planning.

Chapter 4

Results & Recovery

Improvement Timeline

Liver function improvements (albumin, bilirubin, INR) typically begin within 4 to 8 weeks. Fibrosis improvement may be measurable on FibroScan at 6 to 12 months. Most patients report improved energy, reduced ascites, and better overall health within 2 to 3 months.

4-8
Weeks to Lab Improvements
72%
Sustained Liver Function Gain
12-18
Months Average Benefit

Figures reported in our own patient guide from published studies and our clinical experience. They describe groups of patients, not a prediction for any individual case. See the evidence we rely on.

Chapter 5

Getting Started

Next Steps

Contact us with your liver function tests, FibroScan results, and medical history for a free evaluation. Our hepatology team will provide an honest assessment of what stem cell therapy can offer for your specific liver condition.

Frequently asked questions

Stem cell therapy is not a replacement for liver transplant in end-stage liver failure. However, it may improve liver function enough to delay the need for transplant and can benefit patients who are not transplant candidates.

Yes, alcohol cessation is essential before and after stem cell therapy for liver disease. Ongoing alcohol consumption causes continued liver damage that counteracts the regenerative effects of treatment.

Yes, MSC therapy has been safely administered to patients with compensated and decompensated cirrhosis in multiple clinical trials. Careful pre-treatment assessment ensures appropriate patient selection.

Most patients receive one initial course. Repeat treatments at 6 to 12 month intervals may be beneficial for progressive liver disease.

Next steps

Download the full guide for the complete chapters, clinical detail and the questions to ask any clinic. Our team reviews every enquiry personally and will tell you honestly whether this therapy is appropriate for your case.

Medical disclaimer

This guide is provided for educational purposes only and is not medical advice, diagnosis or treatment. Outcomes vary between individuals and no specific result is guaranteed. Always consult a qualified healthcare professional before making medical decisions.